MoneyWorks4Me

Granules India informs about un-audited financial results

24 Jan 2025 Evaluate
Granules India has informed that the Board of Directors of the Company at their meeting has approved the unaudited financial results (Standalone & Consolidated) for the third quarter and nine months ended on December 31, 2024 prepared under Indian Accounting Standards (Ind - AS). Pursuant to regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), they are enclosing the un-audited financial results (Standalone and Consolidated) of the Company for the third quarter and nine months ended on December 31, 2024. We also enclose the Limited Review Report of the Company's Statutory Auditors, as required under Regulation 33 of the Listing Regulations. The meeting of the Board of Directors of the Company commenced at 10.30 AM and concluded at 01.00 PM.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..